文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

验证改良的 Berger HIV 耻辱量表在丙型肝炎病毒(HCV)感染患者中的适用性。

Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection.

机构信息

Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, United States of America.

出版信息

PLoS One. 2020 Feb 5;15(2):e0228471. doi: 10.1371/journal.pone.0228471. eCollection 2020.


DOI:10.1371/journal.pone.0228471
PMID:32023310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7001940/
Abstract

BACKGROUND: Stigma around hepatitis C virus (HCV) infection is an important and understudied barrier to HCV prevention, treatment, and elimination. To date, no validated instrument exists to measure patients' experiences of HCV stigma. This study aimed to revise the Berger (2001) HIV stigma scale and evaluate its psychometric properties among patients with HCV infection. METHODS: The Berger HIV stigma scale was revised to ask about HCV and administered to patients with HCV (n = 270) in Philadelphia, Pennsylvania. Scale reliability was evaluated as internal consistency by calculating Cronbach's alpha. Exploratory factor analysis was performed to evaluate construct validity by comparing item clustering to the Berger HIV stigma scale subscales. Item response theory was employed to further evaluate individual items and to calibrate items for simulated computer adaptive testing sessions in order to identify potential shortened instruments. RESULTS: The revised HCV Stigma Scale was found to have good reliability (α = 0.957). After excluding items for low loadings, the exploratory factor analysis indicated good construct validity with 85% of items loading on pre-defined factors. Analyses strongly suggested the predominance of an underlying unidimensional factor solution, which yielded a 33-item scale after items were removed for low loading and differential item functioning. Adaptive simulations indicated that the scale could be substantially shortened without detectable information loss. CONCLUSIONS: The 33-item HCV Stigma Scale showed sufficient reliability and construct validity. We also conducted computer adaptive testing simulations and identified shortened six- and three-item scale alternatives that performed comparably to the original 40-item scale.

摘要

背景:丙型肝炎病毒(HCV)感染相关污名是 HCV 预防、治疗和消除的一个重要而研究不足的障碍。迄今为止,尚无经过验证的工具可用于衡量患者的 HCV 污名体验。本研究旨在修订 Berger(2001)HIV 污名量表,并评估其在 HCV 感染患者中的心理测量特性。

方法:对 Berger HIV 污名量表进行修订,以询问 HCV 相关问题,并在宾夕法尼亚州费城的 HCV 患者(n=270)中进行评估。通过计算 Cronbach's alpha 评估量表的可靠性,即内部一致性。通过将项目聚类与 Berger HIV 污名量表的亚量表进行比较,进行探索性因素分析,以评估结构效度。采用项目反应理论进一步评估各个项目,并对模拟计算机自适应测试的项目进行校准,以确定潜在的简化工具。

结果:修订后的 HCV 污名量表具有良好的可靠性(α=0.957)。在排除低负荷的项目后,探索性因素分析表明,具有良好的结构效度,85%的项目符合预定义的因子。分析强烈表明存在一个潜在的单一维度因子解决方案,在去除低负荷和不同项目功能的项目后,得到一个 33 项的量表。自适应模拟表明,在没有明显信息损失的情况下,该量表可以大大缩短。

结论:33 项 HCV 污名量表具有足够的可靠性和结构效度。我们还进行了计算机自适应测试模拟,并确定了简化的六和三项目量表替代方案,它们与原始的 40 项量表表现相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/312be19928f6/pone.0228471.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/d7c0ce870a12/pone.0228471.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/f0fd7c9cbf25/pone.0228471.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/312be19928f6/pone.0228471.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/d7c0ce870a12/pone.0228471.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/f0fd7c9cbf25/pone.0228471.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c065/7001940/312be19928f6/pone.0228471.g003.jpg

相似文献

[1]
Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection.

PLoS One. 2020-2-5

[2]
Psychometric assessment of HIV stigma in patients attending a tertiary facility: An initial validation of the Berger HIV stigma scale in a Ghanaian perspective.

PLoS One. 2023

[3]
Development of a 12-item short version of the HIV stigma scale.

Health Qual Life Outcomes. 2017-5-30

[4]
Psychometric evaluation of the HIV stigma scale in a Swedish context.

PLoS One. 2014-12-18

[5]
Validity, reliability, and measurement invariance of an adapted short version of the HIV stigma scale among perinatally HIV infected adolescents at the Kenyan coast.

Glob Health Res Policy. 2021-12-10

[6]
Assessing HIV/AIDS stigma in south India: validation and abridgement of the Berger HIV Stigma scale.

AIDS Behav. 2013-1

[7]
Shortened and Culturally Appropriate HIV Stigma Scale for Asians Living with HIV in the United States: Psychometric Analysis.

J Assoc Nurses AIDS Care. 2018-2-19

[8]
Translation and validation of the Short HIV Stigma scale in Brazilian Portuguese.

Health Qual Life Outcomes. 2020-10-2

[9]
Validity and Reliability of a COVID-19 Stigma Scale Using Exploratory and Confirmatory Factor Analysis in a Sample of Egyptian Physicians: E16-COVID19-S.

Int J Environ Res Public Health. 2021-5-19

[10]
Stigmatizing attitudes towards people living with HIV/AIDS: validation of a measurement scale.

BMC Public Health. 2014-12-4

引用本文的文献

[1]
Perceptions of Stigma Among Patients With Hepatitis B in Germany: Cross-Sectional Survey.

JMIR Form Res. 2025-6-13

[2]
Acceptance of Social Media Recruitment for Clinical Studies Among Patients With Hepatitis B: Mixed Methods Study.

J Med Internet Res. 2024-8-26

[3]
Social challenges experienced by Hepatitis B patients: A mixed method study.

J Family Med Prim Care. 2023-4

[4]
Stigma Scale Adaptation and Validation for Measuring COVID-19 Stigma.

Cureus. 2023-5-8

[5]
Psychometric assessment of HIV stigma in patients attending a tertiary facility: An initial validation of the Berger HIV stigma scale in a Ghanaian perspective.

PLoS One. 2023

[6]
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale.

J Viral Hepat. 2023-7

[7]
Social and self-stigma during COVID-19 pandemic: Egyptians' perspectives.

PLoS One. 2023

[8]
Measuring Stigma Associated with Hepatitis B Virus Infection in Sierra Leone: Validation of an Abridged Berger HIV Stigma Scale.

medRxiv. 2023-2-18

[9]
Construction of a computerized adaptive test (CAT-CCNB) for efficient neurocognitive and clinical psychopathology assessment.

J Neurosci Methods. 2023-2-15

[10]
Development & validation of scales to assess stigma related to COVID-19 in India.

Indian J Med Res. 2022-1

本文引用的文献

[1]
Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?

PLoS One. 2018-11-30

[2]
Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.

PLoS One. 2018-11-28

[3]
Cultural validation of a new instrument to measure leprosy-related stigma: the SARI Stigma Scale.

Lepr Rev. 2017-3

[4]
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study.

Open Forum Infect Dis. 2018-6-7

[5]
Development and public release of a computerized adaptive (CAT) version of the Schizotypal Personality Questionnaire.

Psychiatry Res. 2018-2-8

[6]
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.

Open Forum Infect Dis. 2017-12-9

[7]
Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.

AIDS Res Hum Retroviruses. 2018-2

[8]
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

J Int AIDS Soc. 2017-7-28

[9]
Development of a 12-item short version of the HIV stigma scale.

Health Qual Life Outcomes. 2017-5-30

[10]
Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.

Can J Gastroenterol Hepatol. 2017-4-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索